These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 100771)

  • 1. [Preliminary studies on the preparation of vaccine against Psudomonas aeruginosa patients with burns].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W; Zietkiewicz W
    Pol Tyg Lek; 1978 Sep; 33(39):1533-6. PubMed ID: 100771
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
    Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
    Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
    Meitert E; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pseudomonas multicomponent vaccine in major burn patients].
    Mizuno H; Ashikawa K
    Nihon Rinsho; 1991 Oct; 49(10):2425-30. PubMed ID: 1749100
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological control of pseudomonas infection in burns.
    R I Med J; 1972 Mar; 55(3):88. PubMed ID: 4622683
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
    Okada K; Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice].
    Grochowski J; Bilinska M; Stankiewicz D; Arkusiewicz E
    Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210
    [No Abstract]   [Full Text] [Related]  

  • 13. Low mortality in burned patients in a Pseudomonas vaccine trial.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1978 Aug; 2(8086):401-3. PubMed ID: 79764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of elastase, protease and common antigen (OEP) from Pseudomonas aeruginosa on protection against burns in mice.
    Kawaharajo K; Homma JY
    Jpn J Exp Med; 1977 Dec; 47(6):495-500. PubMed ID: 416253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine.
    Pranter W; Staerk J; Zellner R; Zwisler O
    Prog Immunobiol Stand; 1971; 5():414-8. PubMed ID: 4633968
    [No Abstract]   [Full Text] [Related]  

  • 16. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns.
    Jones RJ; Lowbury EJ
    Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.
    Jones RJ
    Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental vaccinal prophylaxis of Pseudomonas aeruginosa burn sepsis].
    Bandman OA; Stanislavskiĭ ES; Kholodkova EV; Ivanova TV; Salov VF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):59-62. PubMed ID: 2510430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
    Gerasimova LI; Moroz AF; Radkevich SA; Sveshnikov AI; Mizikin EV
    Khirurgiia (Mosk); 1980 Nov; (11):36-41. PubMed ID: 6777578
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF; Kharitonova AM; Chanturiia TsK
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.